Summer Street Research Partners Closes Financing for Novadaq Technologies
Inc.
</pre> <p><span class="xn-location">BOSTON</span>, <span class="xn-chron">Feb. 23</span> /CNW/ -- <span class="xn-person">Summer Street</span> Research Partners is pleased to announce the recent closing of a financing for Novadaq Technologies, a company that develops and markets real-time fluorescence imaging technology products for use in the operating room. Novadaq, a publicly traded company on the <span class="xn-location">Toronto</span> Stock Exchange (NDQ), raised CDN$7.4 million (USD$7.1 million). The capital was raised primarily from U.S. based institutional investors and <span class="xn-person">Summer Street</span> Research Partners served as the exclusive U.S. placement agent.</p> <p/> <p><span class="xn-person">Summer Street</span> Research Partners is an institutional equity research and trading firm that focuses exclusively on the healthcare sector. Since its founding in 2002, the firm's premier product has been its proprietary equity research. We utilize more than 4,000 physicians and industry professionals provided through Medical Consulting Research Inc. (MCRI), a division of <span class="xn-person">Summer Street</span> Research Partners, to conduct primary research. <a href="http://www.ssrp.com">www.ssrp.com</a></p> <p/> <p> </p> <p> </p> <pre> Contact: Matthew H. Dormer Director, Investment Banking Summer Street Research Partners 617-532-6412 [email protected]
For further information: For further information: Matthew H. Dormer, Director, Investment Banking, Summer Street Research Partners, +1-617-532-6412, [email protected] Web Site: http://www.ssrp.com
Share this article